Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Significance of CD133 Expression in Invasive Ductal Carcinoma of the Breast

NCT04873154 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT04873154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04873154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Significance of CD133 Expression in Invasive Ductal Carcinoma of the Breast
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2021
Completion date
December 1, 2021
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer